Cite
HARVARD Citation
Fehmi, J. et al. (2022). IgG1 pan-neurofascin antibodies define a severe and frequently fatal GBS-like neuropathy which responds to rituximab. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fehmi, J. et al. (2022). IgG1 pan-neurofascin antibodies define a severe and frequently fatal GBS-like neuropathy which responds to rituximab. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A1. [Online].